A Delaware federal judge refused Thursday to hand Seattle-based NanoString Technologies Inc. a win on certain gene technology patent infringement claims asserted by rival 10x Genomics, barring NanoString from arguing that the patent claims are too indefinite to be protected and sending the case to a November jury trial.